Reversible Mitochondrial Protein Acetylation and Metabolic Regulation
Reversible Mitochondrial Protein Acetylation and Metabolic Regulation
批准号:
8496766
负责人:
Eric M. Verdin
金额:
$155.38万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-06-01 至 2015-06-30
关键词:
AcetylationAgingAmino AcidsAnimal ModelBiologicalBiological ProcessBudgetsCaloric RestrictionCell modelCellsChronicClinicalCoupledDataDeacetylaseDeacetylationDevelopmentDiabetes MellitusDietDiseaseElectron TransportEnzymesFastingFatty AcidsFatty acid glycerol estersFundingGlucoseGoalsGrantHomeostasisHumanImmune SeraInflammationInsulin ResistanceIslets of LangerhansKnock-outLinkLipidsLiverLysineMalignant NeoplasmsMass Spectrum AnalysisMeasurementMetabolicMetabolic ControlMetabolic DiseasesMetabolic syndromeMetabolismMitochondriaMitochondrial ProteinsModelingMolecularMolecular BiologyMonoclonal Antibody R24MusMuscleMutationNon-Insulin-Dependent Diabetes MellitusObesityOxidative StressPancreasPathogenesisPathologicPathway interactionsPhosphotransferasesPhysiologicalPlayPreventionProcessProductionProtein AcetylationProtein AnalysisProteomicsRegulationReportingResolutionRoleSirtuinsSiteSteatohepatitisStreptozocin DiabetesStressSyndromeTestingTissue EngineeringTissuesTransgenic OrganismsUnited States National Institutes of HealthVariantbasedb/db mouseenzyme pathwayfatty acid oxidationfeedingflexibilityin vivoinsulin sensitivityinsulin signalingketogenesismetabolomicsmitochondrial dysfunctionmouse modelmultidisciplinarynovelnovel therapeuticsoverexpressionoxidationpyruvate dehydrogenasetoolverdin photosensitizer
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This is a competitive renewal of an R24 grant focused on SIRT3, the major mitochondrial protein deacetylase. Our initial funding was limited to two years due to NIH budget constraints, but we believe that during the first 18 months of this grant we have made great progress in forming and an interdisciplinary team that has defined novel biological functions of SIRT3 and its role in regulation of systemic metabolism. We have found that SIRT3 expression is differentially regulated in liver and muscle in fasting and diabetes. In liver, increased SIRT3 during fasting leads to deacetylation of key mitochondrial enzymes in the fatty acid oxidation pathway and to an increase in their enzymatic activities. In contrast, SIRT3 expression decreases in muscle during fasting, leading to hyperacetylation of pyruvate dehydrogenase and several components of the electron transport chain. Metabolomic analysis of SIRT3KO reveals possible tissue-specific differences in regulation of fatty acid, glucose, and amino acid oxidation that will be explored further in the current application. These studies clearl show that SIRT3KO mice have defective fatty acid oxidation in liver and reduced metabolic flexibility and reduced ATP levels in muscle, as well as insulin resistance due to increased ROS and activation of stress kinases. Furthermore, SIRT3KO mice placed on a high fat diet show accelerated development of a syndrome that mimics human metabolic syndrome with obesity, type 2 diabetes, lipid abnormalities, and steatohepatitis. Together these findings point to a role of reversible mitochondrial protein acetylation as a key regulator of mitochondrial metabolism and SIRT3 as a potentially important factor in the pathogenesis of type 2 diabetes and the metabolic syndrome. The overall goal of this proposal is to extend these studies to completely define the role of protein acetylation and SIRT3 in mitochondrial function and control of metabolism. We will take advantage of our highly collaborative and multidisciplinary team harnessing the power of mass spectrometry-based proteomics, metabolomics, molecular biology, extensive physiological testing and unique animal models to further expand our understanding of this important process in regulation of mitochondrial function and metabolism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
-
批准号:10187413
-
项目类别:
-
资助金额:$58.2万
-
财政年份:2021
-
负责人:Eric M. Verdin
-
依托单位:
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
-
批准号:10491086
-
项目类别:
-
资助金额:$58.01万
-
财政年份:2021
-
负责人:Eric M. Verdin
-
依托单位:
Senescence, NAD+ decrease and Alzheimer's disease and related dementias Alzheimer's disease and related dementias
-
批准号:10647780
-
项目类别:
-
资助金额:$57.82万
-
财政年份:2021
-
负责人:Eric M. Verdin
-
依托单位:
Molecular Mechanisms of HIV Latency
-
批准号:10308273
-
项目类别:
-
资助金额:$6.89万
-
财政年份:2016
-
负责人:Eric M. Verdin
-
依托单位:
Lysine Malonylation and SIRT5 in Epigenetic Regulation
-
批准号:9198466
-
项目类别:
-
资助金额:$3.3万
-
财政年份:2016
-
负责人:Eric M. Verdin
-
依托单位:
Molecular Mechanisms of HIV Latency
-
批准号:10200723
-
项目类别:
-
资助金额:$126.08万
-
财政年份:2016
-
负责人:Eric M. Verdin
-
依托单位:
Molecular Mechanisms of HIV Latency
-
批准号:9547084
-
项目类别:
-
资助金额:$127.88万
-
财政年份:2016
-
负责人:Eric M. Verdin
-
依托单位:
Molecular Mechanisms of HIV Latency
-
批准号:9421554
-
项目类别:
-
资助金额:$126.63万
-
财政年份:2016
-
负责人:Eric M. Verdin
-
依托单位:
Molecular Mechanisms of HIV Latency
-
批准号:10409598
-
项目类别:
-
资助金额:$13.78万
-
财政年份:2016
-
负责人:Eric M. Verdin
-
依托单位:
Identification of HIV latency biomarkers with a dual fluorescence reporter HIV
-
批准号:9231361
-
项目类别:
-
资助金额:$69.16万
-
财政年份:2015
-
负责人:Eric M. Verdin
-
依托单位:
Identification of HIV latency biomarkers with a dual fluorescence reporter HIV
-
批准号:8892911
-
项目类别:
-
资助金额:$70.5万
-
财政年份:2015
-
负责人:Eric M. Verdin
-
依托单位:
Identification of HIV latency biomarkers with a dual fluorescence reporter HIV
-
批准号:9903192
-
项目类别:
-
资助金额:$69.48万
-
财政年份:2015
-
负责人:Eric M. Verdin
-
依托单位:
Regulation of HIV latency for Chromatin
-
批准号:8326774
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2011
-
负责人:Eric M. Verdin
-
依托单位:
MOLECULAR MECHANISMS OF HIV POST-INTEGRATION LATENCY
-
批准号:8357270
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2011
-
负责人:Eric M. Verdin
-
依托单位:
Epigenetic regulation of HIV latency
-
批准号:8214671
-
项目类别:
-
资助金额:$44.12万
-
财政年份:2010
-
负责人:Eric M. Verdin
-
依托单位:
Novel Model for HIV Latency in Primary Memory T Cells
-
批准号:8706838
-
项目类别:
-
资助金额:$93.61万
-
财政年份:2010
-
负责人:Eric M. Verdin
-
依托单位:
Reversible Mitochondrial Protein Acetylation and Metabolic Regulation
-
批准号:9100715
-
项目类别:
-
资助金额:$155.06万
-
财政年份:2010
-
负责人:Eric M. Verdin
-
依托单位:
Novel Model for HIV Latency in Primary Memory T Cells
-
批准号:8082543
-
项目类别:
-
资助金额:$96.5万
-
财政年份:2010
-
负责人:Eric M. Verdin
-
依托单位:
Epigenetic regulation of HIV latency
-
批准号:8434038
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2010
-
负责人:Eric M. Verdin
-
依托单位:
REVERSIBLE MITOCHONDRIAL PROTEIN ACETYLATION AND METABOLIC REGULATION
-
批准号:8074362
-
项目类别:
-
资助金额:$165.57万
-
财政年份:2010
-
负责人:Eric M. Verdin
-
依托单位:
海外基金